Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Understanding and exploiting the roles of O-GlcNAc in neurodegenerative diseases

Journal of Biological Chemistry(2023)10.1016/j.jbc.2023.105411Source: DataRank Database

Understanding and exploiting the roles of O-GlcNAc in neurodegenerative diseases is a research paper published in Journal of Biological Chemistry (2023). On theSindex it has a DataRank of 0.590. It has been cited 50 times.

N/A

0.590DataRank · unranked

Scored on demand from live citation data

Open Access50 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 4.55)OA: goldTopics (51)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.590

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (2)

David J. Vocadlo ORCID,Matthew R. Pratt ORCID

Live enrichment

PubMed:37918804 OpenAlex:https://openalex.org/W4388074463

National Institutes of Health

Grant: R01GM114537

NIGMS

Grant: R01GM125939

Canadian Institutes of Health Research

Grant: PJT-156202

Natural Sciences and Engineering Research Council of Canada

Grant: RGPIN-05426

National Institutes of Health

Grant: 5R01GM114537-07

Functional Analysis of O-GlcNAc using Synthetic Protein Chemistry

National Institutes of Health

Grant: 5R01GM125939-03

Chemical Tools for the Investigation and Manipulation of Protein Glycosylation

Canadian Institutes of Health Research

Grant: unidentified

unidentified

CIHR

FWCI

4.55

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.jbc.2023.105411

publisherhttps://doi.org/10.1016/j.jbc.2023.105411

publisherhttps://api.elsevier.com/content/article/PII:S0021925823024390?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0021925823024390?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37918804

Fields of Study

Glycosylation and Glycoproteins ResearchCarbohydrate Chemistry and SynthesisUbiquitin and proteasome pathways03 medical and health sciences0302 clinical medicineHumansAcetylglucosamineAlzheimer DiseaseAmyloid beta-Protein Precursorbeta-N-AcetylhexosaminidasesN-AcetylglucosaminyltransferasesParkinson DiseaseProtein Processing, Post-TranslationalEnzyme Inhibitors

MeSH Terms

AcetylglucosamineAlzheimer Diseasebeta-N-AcetylhexosaminidasesEnzyme InhibitorsHumansParkinson DiseaseProtein Processing, Post-TranslationalAmyloid beta-Protein PrecursorN-AcetylglucosaminyltransferasesNeurodegenerative Diseases

Keywords

NeurodegenerationDiseaseMechanism (biology)AutophagyEnzymeChemistryBiochemistryBiologyComputational biologyNeuroscienceMedicineAmyloid beta-Protein PrecursorAlzheimer DiseaseJBC ReviewsHumansParkinson DiseaseEnzyme InhibitorsN-AcetylglucosaminyltransferasesProtein Processing, Post-Translationalbeta-N-AcetylhexosaminidasesAcetylglucosamineAlzheimer's diseaseO-GlcNAcclinical developmentprotein synthesissynucleintau

Sustainable Development Goals

SDG 0: Good health and well-being